Cefdinir Powder, For Suspension
Product Images NDC 68788-8115

2 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68788-8115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir-structure (Cefdinir Structure)

Cefdinir-structure (Cefdinir Structure)
Chemical structure diagram of cefdinir, the active ingredient shown in the product data. It depicts the molecular arrangement with labeled atoms and bonds characteristic of cefdinir.*
FDA Label Image

Cefdinir For Oral Suspension Usp 125mg/5ml (5ml)

Cefdinir For Oral Suspension Usp 125mg/5ml (5ml)
Label for Cefdinir for Oral Suspension USP, 125 mg/5 mL, a powder for suspension by Preferred Pharmaceuticals Inc. The label states it is generic for Omnicef and includes instructions to reconstitute with 40 mL water. Manufacturer listed as Ascend Laboratories, LLC. The label contains warnings, expiration and lot number placeholders, a barcode, and bilingual English and Spanish directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.